BiotechTube
Home/Pipeline/BAY 1895344

BAY 1895344

Advanced solid tumors

Phase 1Active

Key Facts

Indication
Advanced solid tumors
Phase
Phase 1
Status
Active
Company
Bayer

About Bayer

Bayer AG is one of the world's largest pharmaceutical and life sciences companies, headquartered in Leverkusen, Germany. The company develops and commercializes innovative therapies across oncology, cardiology, ophthalmology, and hematology, while also maintaining leading positions in consumer health products and agricultural sciences. With operations in over 100 countries and approximately 100,000 employees globally, Bayer continues to focus on breakthrough innovations in health and nutrition.

View full company profile

Therapeutic Areas

OncologyCardiologyOphthalmologyHematologyNephrologyConsumer Health

Other Advanced solid tumors Drugs

DrugCompanyPhase
SHR-1701Jiangsu Hengrui MedicinePhase 1
HS-10342Hansoh PharmaPhase 1/2
ANKTIVA® + M-ceNKImmunityBioPhase 1
DFTX-101Definium TherapeuticsPhase 1/2
REC-617Recursion PharmaceuticalsPhase 1/2
ZW220ZymeworksPreclinical
NX-1607Nurix TherapeuticsPhase 1a
IMA402 (TCR Bispecific)ImmaticsPhase 1
IMA403 (TCR Bispecific)ImmaticsPre-clinical
BCA101Bicara TherapeuticsPhase 1
AN4005Adlai NortyePreclinical
AN3025Adlai NortyePreclinical